Literature DB >> 8954824

Effects of lambda-carrageenan induced experimental enterocolitis on splenocyte function and nitric oxide production.

V E Pricolo1, S M Madhere, S D Finkelstein, J S Reichner.   

Abstract

A lambda-carrageenan induced rat model of inflammatory bowel disease (IBD) allowed evaluation of progressive histopathological changes over time and comparison with human disease. In addition, this model was used to test the hypothesis that the immunosuppression observed in IBD may be mediated in part by augmented production of nitric oxide by splenic lymphocytes. Male Sprague-Dawley rats were fed standard rat chow and a drinking solution of 2% lambda-carrageenan without prior sensitization to the compound. At 2, 4, 6, and 8 weeks, small and large intestines were removed for histological examination, and splenocytes were assayed for response to various mitogens and for nitrite production. Intestinal lesions gradually developed in lambda-carrageenan fed rats and were found to be morphologically similar to those observed in human ulcerative colitis. The proliferative response of splenocytes to known mitogens was significantly diminished in carrageenan fed rats, when compared with pair-fed controls, but was fully restored when cultured in the presence of NG-monomethyl-L-arginine, a specific inhibitor of nitric oxide synthase. Preliminary data suggest that overproduction of nitric oxide may provide a molecular mechanism for the immunosuppression observed during chronic inflammatory bowel disease. Further characterization of a reproducible rat model of IBD will allow further investigation into the pathogenesis of the human disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8954824     DOI: 10.1006/jsre.1996.0364

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  7 in total

Review 1.  Nitric oxide as a modulator of intestinal water and electrolyte transport.

Authors:  A A Izzo; N Mascolo; F Capasso
Journal:  Dig Dis Sci       Date:  1998-08       Impact factor: 3.199

2.  Carrageenan inhibits granzyme A-induced detachment of and interleukin-8 release from alveolar epithelial A549 cells.

Authors:  Yumiko Yoshikawa; Hirofumi Hirayasu; Satoshi Tsuzuki; Tohru Fushiki
Journal:  Cytotechnology       Date:  2008-11-06       Impact factor: 2.058

3.  Detection of inflammatory bowel disease by proton magnetic resonance spectroscopy (1H MRS) using an animal model.

Authors:  Sonal Varma; Ranjana Bird; Michael Eskin; Brion Dolenko; Jayadev Raju; Tedros Bezabeh
Journal:  J Inflamm (Lond)       Date:  2007-11-26       Impact factor: 4.981

Review 4.  The Role of Carrageenan and Carboxymethylcellulose in the Development of Intestinal Inflammation.

Authors:  John Vincent Martino; Johan Van Limbergen; Leah E Cahill
Journal:  Front Pediatr       Date:  2017-05-01       Impact factor: 3.418

5.  Plasma proteome responses in zebrafish following λ-carrageenan-Induced inflammation are mediated by PMN leukocytes and correlate highly with their human counterparts.

Authors:  Ives Charlie-Silva; Natália M Feitosa; Leticia G Pontes; Bianca H Fernandes; Rafael H Nóbrega; Juliana M M Gomes; Mariana N L Prata; Fausto K Ferraris; Daniela C Melo; Gabriel Conde; Letícia F Rodrigues; Mayumi F Aracati; José D Corrêa-Junior; Wilson G Manrique; Joshua Superio; Aguinaldo S Garcez; Katia Conceição; Tania M Yoshimura; Silvia C Núñez; Silas F Eto; Dayanne C Fernandes; Anderson Z Freitas; Martha S Ribeiro; Artem Nedoluzhko; Mônica Lopes-Ferreira; Ricardo C Borra; Leonardo J G Barcellos; Andrea C Perez; Guilheme Malafaia; Thiago M Cunha; Marco A A Belo; Jorge Galindo-Villegas
Journal:  Front Immunol       Date:  2022-09-29       Impact factor: 8.786

6.  Bovine colostrum in oral treatment of enterogenic endotoxaemia in rats.

Authors:  J Rüdiger Döhler; Lars Nebermann
Journal:  Crit Care       Date:  2002-09-25       Impact factor: 9.097

Review 7.  A review on chemical-induced inflammatory bowel disease models in rodents.

Authors:  Puneet Kaur Randhawa; Kavinder Singh; Nirmal Singh; Amteshwar Singh Jaggi
Journal:  Korean J Physiol Pharmacol       Date:  2014-08-13       Impact factor: 2.016

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.